STATCenter·
STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds
The median net price for 202 newly launched medicines rose by 35%, to $257,000 last year from $173,000 in 2022.
Read at STAT →
Health · 1 sources covering this
STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds
The median net price for 202 newly launched medicines rose by 35%, to $257,000 last year from $173,000 in 2022.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/0864f14da64b405ec6069c9e984ae144a6960f41" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds"></iframe>
